Active or passive enhancement and allograft survival.
D000818:Animals; D000941:Antigens / Q000302:isolation & purification; D003601:Cytotoxicity Tests, Immunologic; D004285:Dogs; D006084:Graft Rejection; D006087:Graft vs Host Reaction; D006649:Histocompatibility Antigens; D006801:Humans; D007106:Immune Sera; D007116:Immunization, Passive; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D007962:Leukocytes / Q000276:immunology; D008099:Liver / Q000166:cytology; D009928:Organ Specificity; D010206:Papain / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000166:cytology; D013156:Splenectomy; D014181:Transplantation Immunology; D014184:Transplantation, Homologous; D014465:Ultrasonics
D000941:Antigens; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007140:Immunoglobulin Fab Fragments; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D010206:Papain